BioCentury | Feb 21, 2011
Company News

sanofi-aventis, Sunnybrook Health Sciences Center deal

...milestones and royalty payments. Financial terms were not disclosed. sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France Sunnybrook Health Sciences Center...
BioCentury | Nov 4, 1996
Company News

Gilead other research news

GILD and colleagues at the Sunnybrook Health Science Center in Toronto showed that p27, a cyclin-dependent kinase inhibitor known to be up-regulated by intercellular contact in normal cells, plays a role in the resistance of...
Items per page:
1 - 2 of 2
BioCentury | Feb 21, 2011
Company News

sanofi-aventis, Sunnybrook Health Sciences Center deal

...milestones and royalty payments. Financial terms were not disclosed. sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France Sunnybrook Health Sciences Center...
BioCentury | Nov 4, 1996
Company News

Gilead other research news

GILD and colleagues at the Sunnybrook Health Science Center in Toronto showed that p27, a cyclin-dependent kinase inhibitor known to be up-regulated by intercellular contact in normal cells, plays a role in the resistance of...
Items per page:
1 - 2 of 2